[Congressional Bills 108th Congress]
[From the U.S. Government Publishing Office]
[S. 1579 Introduced in Senate (IS)]
108th CONGRESS
1st Session
S. 1579
To provide for the continuation of the Pediatric Research Initiative.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
September 3, 2003
Mr. DeWine introduced the following bill; which was read twice and
referred to the Committee on Health, Education, Labor, and Pensions
_______________________________________________________________________
A BILL
To provide for the continuation of the Pediatric Research Initiative.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. PEDIATRIC RESEARCH INITIATIVE.
The Director of the National Institutes of Health in implementing
the Pediatric Research Initiative under section 409D of the Public
Health Service Act (42 U.S.C. 284h), shall--
(1) continue the Initiative and emphasize the importance of
pediatric research, particularly translational research; and
(2) not later than January of 2004, continue to report to
the Committee on Health, Education, Labor, and Pensions of the
Senate and the Committee on Energy and Commerce of the House of
Representatives on the status of the Pediatric Research
Initiative, including--
(A) the extent of the total funds obligated to
conduct or support pediatric research across the
National Institutes of Health, including the specific
support and research awards allocated by the Office of
the Director through the Initiative;
(B) the activities of the cross-institute committee
on pediatric research in assisting the Director in
considering requests for new or expanded pediatric
research to be funded through the Initiative;
(C) how the Director plans to budget dollars toward
the Initiative for fiscal year 2004;
(D) the amount the Director has expended to
implement the Initiative since the enactment of the
Initiative;
(E) the status of any research conducted as a
result of the Initiative;
(F) whether that research is translational research
or clinical research;
(G) how the Initiative interfaces with the Off-
Patent research fund of the National Institutes of
Health; and
(H) any recommended modifications that Congress
should consider in the authority or structure of the
Initiative within the National Institutes of Health for
the optimal operation and success of the Initiative.
<all>